Antimicrobial ophthalmic devices comprising polysiloxane-polyglycerol block copolymers and methods of making and use thereof

1. An antimicrobial ophthalmic device comprising:

a silicone hydrogel composition and an antimicrobial agent,

wherein the silicone hydrogel composition comprises an actinically-crosslinkable polysiloxane-polyglycerol block copolymer crosslinked with a crosslinker,

wherein the actinically-crosslinkable polysiloxane-polyglycerol block copolymer is derived from: a polysiloxane prepolymer comprising a polyglycerol side chain, the polyglycerol side chain comprising an ethylenically unsaturated group covalently linked thereto, wherein the ethylenically unsaturated group is actinically curable.

2. The antimicrobial ophthalmic device of claim 1 , wherein the antimicrobial ophthalmic device comprises a contact lens, an introcular lens, a corneal inlay, an eye bandage, a drug delivery device, a prosthetic device, or a combination thereof.

3. The antimicrobial ophthalmic device of claim 1 , wherein the antimicrobial ophthalmic device comprises a contact lens and the contact lens is cosmetically tinted.

4. The antimicrobial ophthalmic device of claim 1 , wherein the antimicrobial agent comprises a quaternary ammonium compound, an antimicrobial metal, an antimicrobial monomer, or a combination thereof.

5. The antimicrobial ophthalmic device of claim 1 , wherein the antimicrobial agent comprises a quaternary ammonium compound.

6. The antimicrobial ophthalmic device of claim 1 , wherein the antimicrobial agent comprises an antimicrobial metal and the antimicrobial metal comprises Ag, Au, Pt, Pd, Ir, Sn, Cu, Sb, Bi, or Zn.

7. The antimicrobial ophthalmic device of claim 1 , wherein the antimicrobial agent comprises a plurality of nanoparticles comprising an antimicrobial metal.

8. The antimicrobial ophthalmic device of claim 1 , wherein the antimicrobial agent is provided as a coating, wherein the antimicrobial agent is chemically bound to the silicon hydrogel composition, or a combination thereof.

9. The antimicrobial ophthalmic device of claim 1 , wherein the antimicrobial ophthalmic device has a high oxygen permeability.

10. The antimicrobial ophthalmic device of claim 1 , wherein the polysiloxane prepolymer is linear or branched.

11. The antimicrobial ophthalmic device of claim 1 , wherein the ethylenically unsaturated group is covalently linked to the polyglycerol side chain directly or wherein the ethylenically unsaturated group is covalently linked to the polyglycerol side chain through a linking group.

12. The antimicrobial ophthalmic device of claim 1 , wherein the ethylenically unsaturated group comprises acryloyl, acrylamide, alkyl acrylamide, dialkyl acrylamide, methacryloyl, allyl, vinyl, styrenyl, or a combination thereof.

13. The antimicrobial ophthalmic device of claim 1 , wherein the actinically-crosslinkable polysiloxane-polyglycerol block copolymer is defined by Formula I:

wherein

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and J 1 are, independently, alkyl, cycloalkyl, aryl, alkylpolyethylene oxide, or polyglycerol, any of which is optionally substituted with halide, hydroxy, thiol, carbonyl, alkoxy, alkylhydroxy, carboxyl, amino, amido, alkyl, alkenyl, alkynyl, aryl, —NR x R y , —C(O)NR x R y , azide, or a combination thereof;

Q 1 and Q 2 are independently H, OH, amino, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylaryl, or heteroaryl, any of which is optionally substituted with epoxy, hydroxy, thiol, carbonyl, alkoxy, alkylhydroxy, carboxyl, amino, amido, alkyl, alkenyl, alkynyl, aryl, —NR x R y , —C(O)NR x R y , azide, or a combination thereof;

R x and R y are independently H, OH, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylaryl, or heteroaryl;

Cure Group comprises the ethylenically unsaturated group;

a, c, d, e, f, g, h, i, j, and k are, independently, an integer from 0 to 10,000; with the proviso that: at least one of e, g, h, and j is not 0, and at least one of d, f, i, and k is not 0; and

b is an integer from 1 to 10,000.

14. The antimicrobial ophthalmic device of claim 13 , wherein:

R 1 -R 11 and J 1 are, independently, C 1 -C 18 alkyl, C 3 -C 18 cycloalkyl, C 3 -C 20 aryl, alkylpolyethylene oxide, or polyglycerol, any of which is optionally substituted;

Q 1 and Q 2 are independently C 1 -C 18 alkyl, C 3 -C 20 aryl, C 1 -C 18 perfluoroalkyl, C 1 -C 18 alkanol, C 1 -C 18 alkylthiol, C 1 -C 18 alkylamine, C 1 -C 18 dialkylamine, any of which is optionally substituted; and

the Cure Group is selected from the group consisting of:

wherein

R a is H, alkyl, or cycloalkyl, either of which is optionally substituted with halide, hydroxy, alkylthiol, carbonyl, alkoxy, alkylhydroxy, carboxyl, amino, amido, alkyl, alkenyl, alkynyl, aryl, —NR x R y , —C(O)NR x R y , or a combination thereof; and

R x and R y are independently H, OH, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylaryl, or heteroaryl.

15. The antimicrobial ophthalmic device of claim 1 , wherein the polysiloxane prepolymer comprises polydimethylsiloxane.

16. The antimicrobial ophthalmic device of claim 1 , wherein the actinically-crosslinkable polysiloxane-polyglycerol block copolymer is defined by Formula IX, Formula X, or Formula XI:

wherein

a, c, e, f, i, j and k are, independently, an integer from 0 to 10,000; with the proviso that: at least one of e and j is not 0, and at least one of f, i, and k is not 0; and

b is an integer from 1 to 10,000.

17. The antimicrobial ophthalmic device of claim 1 , wherein the actinically-crosslinkable polysiloxane-polyglycerol block copolymer comprises a methacrylated polydimethylsiloxane-polyglycerol block copolymer; a chain extended actinically-crosslinkable polysiloxane-polyglycerol block copolymer; or a combination thereof.

18. The antimicrobial ophthalmic device of claim 1 , wherein the actinically-crosslinkable polysiloxane-polyglycerol block copolymer comprises a chain extended actinically-crosslinkable polysiloxane-polyglycerol block copolymer and the chain extended actinically-crosslinkable polysiloxane-polyglycerol block copolymer is defined by Formula XII:

wherein

R 1 , R 1′ , R 2 , R 2′ , R 3 , R 3′ , R 4 , R 4′ , R 5 , R 5′ , R 6 , R 6′ , R 7 , R 7′ , R 8 , R 8′ , R 9 , R 9′ , R 10 , R 10′ , R 11 , R 11′ , J 1 , and J 1′ are, independently, alkyl, cycloalkyl, aryl, alkylpolyethylene oxide, or polyglycerol, any of which is optionally substituted with halide, hydroxy, thiol, carbonyl, alkoxy, alkylhydroxy, carboxyl, amino, amido, alkyl, alkenyl, alkynyl, aryl, —NR x R y , —C(O)NR x R y , azide, or a combination thereof;

Q 1 , Q 1′ , Q 2 , and Q 2′ are independently H, OH, amino, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylaryl, or heteroaryl, any of which is optionally substituted with epoxy, hydroxy, thiol, carbonyl, alkoxy, alkylhydroxy, carboxyl, amino, amido, alkyl, alkenyl, alkynyl, aryl, —NR x R y , —C(O)NR x R y , azide, or a combination thereof;

R x and R y are independently H, OH, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylaryl, or heteroaryl;

Cure Group and Cure Group′ independently comprise an ethylenically unsaturated group;

Z is a chain extension group;

a, a′, c, c′, d, d′, e, e′, f, f′, g, g′, h, h′, i, i′, j, j′, k, and k′ are, independently, an integer from 0 to 10,000,

with the proviso that:

at least one of e, g, h, and j is not 0,

at least one of e′, g′, h′, and j′ is not 0,

at least one of d, f, i, and k is not 0, and

at least one of d′, f, i′, and k′ is not 0; and

b and b′ are independently an integer from 1 to 10,000.

19. The antimicrobial ophthalmic device of claim 18 , wherein:

R 1 -R 11 , R 1′ -R 11′ , J 1 , and J 1′ are, independently, C 1 -C 18 alkyl, C 3 -C 18 cycloalkyl, C 3 -C 20 aryl, alkylpolyethylene oxide, or polyglycerol, any of which is optionally substituted;

Q 1 , Q 1′ , Q 2 , and Q 2′ are independently H, OH, aryl, epoxide, alkanol, alkylthio, alkenylthio, arylthio, amine, alkylamine, dialkylamine, (meth)acrylate, (meth)acrylamide, dialkyl (meth)acrylamide, vinyl, ketone, aldehyde, carboxylic acid, anhydride, or azide, any of which is optionally substituted; and

Cure Group and Cure Group′ are independently selected from the group consisting of:

wherein

R a is H, alkyl, or cycloalkyl, either of which is optionally substituted with halide, hydroxy, alkylthiol, carbonyl, alkoxy, alkylhydroxy, carboxyl, amino, amido, alkyl, alkenyl, alkynyl, aryl, —NR x R y , —C(O)NR x R y , or a combination thereof, and

R x and R y are independently H, OH, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylaryl, or heteroaryl.

20. The antimicrobial ophthalmic device of claim 1 , wherein the silicone hydrogel composition further comprises a hydrophilic monomer, a hydrophobic monomer, an amphiphilic monomer, a zwitterionic monomer, a UV-blocker, a blue light blocker, an antimicrobial monomer, a dye, a pigment, a solvent, or a combination thereof.